"We expect the approval from the WHO in the fall", Dmitriev told India Today.
Sputnik V, the world's first registered coronavirus vaccine, has been approved for emergency use in 67 countries across the globe. Its efficacy is estimated to be at 97.6%, according to an analysis of data on vaccinated Russians.
Earlier this week, the Gamaleya Research Centre and the Russian Direct Investment Fund (RDIF) said that the vaccine is effective against new coronavirus variants.